Dr. Hoyoung Huh is the Founder of pH Pharma and also serves as Co-Chief Executive Officer & Chairman. He also is an Angel Investor. Dr. Hoyoung Huh serves as Managing Partner at Quintessa Investment. He is a Co-Founder and serves as Chairman of the Scientific Advisory Board and Business Development and Director of AntriaBio. He served as Managing Director at Konus Advisory Group. He is the Chairman of the Board of Geron and Cytomx Therapeutics. He serves as a Board Member at Eidos Therapeutics. Additionally, he serves on the board of directors of several privately-held companies. He served as CEO of BiPar Sciences, which was acquired by Sanofi